群发资讯网

返回主页
bevacizumab
贝伐单抗
常用释义
英式发音
美式发音
基本释义
  • 贝伐单抗
例句
  • 1·Bevacizumab is given intravenously every two to three weeks.
    贝伐单抗是静脉给予每两至三个星期。
  • 2·Bevacizumab treatment was associated with a low rate of serious adverse events.
    贝伐单抗治疗法与低概率的严重不良反应有关。
  • 3·Patients taking higher dosages of bevacizumab had the greatest risk of developing proteinuria.
    接受更高剂量的贝伐单抗的患者有更大的患蛋白尿的风险。
  • 4·Patients taking higher dosages of bevacizumab had the greatest risk of developing proteinuria .
    接受更高剂量的贝伐单抗的患者有更大的患蛋白尿的风险。
  • 5·So if we go back, for example, to the drug bevacizumab in connection with advanced breast cancer...
    因此,让我们回到抗癌药物上来,例如,晚期乳腺癌的药物-贝伐株单抗。
  • 6·As the use of bevacizumab increases, associated adverse effects are being reported more frequently.
    随着贝伐单亢的使用增加,相关的副作用报道的也越来越频繁。
  • 7·The results of two randomized trials looking at the combination of bevacizumab and cetuximab are awaited.
    两项对联合应用贝伐单抗和西妥昔单抗的随机试验结果还须等待。
  • 8·Results A total of 301 patients were randomly assigned to the placebo group and 306 to the bevacizumab group.
    结果:共有301例病人被随机分到安慰剂组,306例被随机分到贝伐单抗组。
  • 9·Bevacizumab is also not used in cases of squamous cell cancer, because it leads to bleeding from this type of lung cancer.
    贝伐单抗,也是没有用的情况下鳞状细胞癌,因为它会导致出血,从这种类型的肺癌。
  • 10·Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab?
    用贝伐单抗治疗复发性卵巢上皮癌的患者中,哪种因素可以预测肠道并发症?